Miist Therapeutics logo — Inhaled Therapies, Instant Relief

Miist Therapeutics

Inhaled Therapies, Instant Relief

Founded 2019 United States Alameda, United States 6 employees Seed Total: $7.08M Health Care, Pharmaceutical

General Information

Company Name Miist Therapeutics
Founded Year 2019
Location United States Alameda, United States
Employees 6
Industries Health Care, Pharmaceutical
Funding Stage Seed
Business Model B2B, B2B2C
Revenue Model Product Sales, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Miist Therapeutics. To contact Miist Therapeutics, visit miisttherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Miist Therapeutics compare?

A PDF of Miist Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Miist Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Miist Therapeutics

Miist Therapeutics, founded in 2019, is making waves in the Health Care and Pharmaceutical industries with their commitment to developing effective addiction treatments. With the slogan, "Addiction Treatments That Work," the company is initially targeting the smoking epidemic—an area where traditional quitting aids have largely failed. The team is dedicated to putting innovative solutions into every smoker's pocket to address the significant health risks associated with cigarette addiction.

Headquartered in the United States, Miist Therapeutics positions itself as a leader in transforming addiction treatment. They secured a $50.00K Seed Round investment on 19 December 2022, backed by notable investors such as StartUp Health and ZeroTo510. This financial support underscores the confidence the investment community has in Miist's unique approach to a longstanding public health challenge.

Business keywords: pharmaceutical company, addiction treatment, smoking cessation, novel treatments, quitting aid, public health, drug development, smoking cessation therapy, nicotine addiction, public health intervention

Services & Products

Development of inhaled therapeutic microparticles
Clinical validation of rapid-acting treatments
Research and development of instant-acting drugs
Creation of novel drug delivery systems

Target Customers

Individuals suffering from migraines Patients seeking quick pain relief People managing anxiety and insomnia Individuals experiencing nausea

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed $7.00M 5
1517 Fund, Entrepreneur First +3
01 Feb 2025
Seed $80.00K -
01 Oct 2022

Miist Therapeutics Alternatives & Competitors

View All Alternatives
Miist Therapeutics vs

Committed to the development of cytisinicline as the first new Rx treatment for nicotine dependence...

Post-IPO Debt
29 employees
Biotechnology, Health Care
Miist Therapeutics vs

A digital health company pioneering nicotine addiction treatment with artificial intelligence and a...

Seed
12 employees
AI, Health Care
Miist Therapeutics vs

Our mission is to treat the world’s largest preventable cause of death – smoking.

Series D
11 employees
Biotechnology, Health Care

FAQ About Miist Therapeutics

Inhaled Therapies, Instant Relief
Miist Therapeutics was founded in 2019.
Miist Therapeutics is headquartered in Alameda, United States.
Miist Therapeutics operates in Health Care and Pharmaceutical. Its work centres on pharmaceutical company, addiction treatment, smoking cessation and novel treatments. Its customers include Individuals suffering from migraines, Patients seeking quick pain relief and People managing anxiety and insomnia.
Miist Therapeutics has a B2B and B2B2C business model. Its revenue comes from Product Sales and Licensing.
Miist Therapeutics has approximately 6 employees.
Miist Therapeutics has completed 2 funding rounds, raising a total of $7.08M. The latest funding stage is Seed.
Miist Therapeutics offers: Development of inhaled therapeutic microparticles, Clinical validation of rapid-acting treatments, Research and development of instant-acting drugs, Creation of novel drug delivery systems.
Top alternatives and competitors to Miist Therapeutics include Achieve Life Sciences, Ditch Labs, Pneuma Respiratory, Inc., Coeptis Therapeutics, InterveXion Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Miist Therapeutics and Achieve Life Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Miist Therapeutics, https://bouncewatch.com/company/miist-therapeutics, updated 22 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes